Thomas A. McCourt
Net Worth

Last updated:

What is Thomas A. McCourt net worth?

The estimated net worth of Mr. Thomas A. McCourt is at least $25,812,329 as of 20 May 2024. He owns shares worth $1,264,213 as insider, has earned $13,213,276 from insider trading and has received compensation worth at least $11,334,840 in Ironwood Pharmaceuticals, Inc..

What is the salary of Thomas A. McCourt?

Mr. Thomas A. McCourt salary is $944,570 per year as Chief Executive Officer & Director in Ironwood Pharmaceuticals, Inc..

How old is Thomas A. McCourt?

Mr. Thomas A. McCourt is 68 years old, born in 1957.

What stocks does Thomas A. McCourt currently own?

As insider, Mr. Thomas A. McCourt owns shares in one company:

Company Title Shares Price per share Total value
Ironwood Pharmaceuticals, Inc. (IRWD) Chief Executive Officer & Director 1,150,330 $1.1 $1,264,213

What does Ironwood Pharmaceuticals, Inc. do?

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

IRWD logo
IRWD
Ironwood Pharmaceuticals, Inc.
$1.1

Thomas A. McCourt insider trading

Ironwood Pharmaceuticals, Inc.

Mr. Thomas A. McCourt has made 41 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold 67,618 units of IRWD stock worth $436,136 on 20 May 2024.

The largest trade he's ever made was exercising 220,000 units of IRWD stock on 30 Aug 2019. As of 20 May 2024 he still owns at least 1,150,330 units of IRWD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 67,618 $6.45 $436,136
Option
Class A Common Stock 120,298 N/A N/A
Option
Performance-based Restricted Stock Unit 120,298 N/A N/A
Sale
Class A Common Stock 177,164 $15.24 $2,699,979
Sale
Class A Common Stock 26,632 $10.7 $284,962
Sale
Class A Common Stock 36,000 $10.12 $364,320
Sale
Class A Common Stock 21,148 $10.62 $224,592
Sale
Class A Common Stock 46,129 $10.67 $492,196
Sale
Class A Common Stock 33,756 $11.22 $378,742
Sale
Class A Common Stock 26,639 $11.31 $301,287
Sale
Class A Common Stock 4,588 $11.31 $51,890
Sale
Class A Common Stock 4,409 $11.41 $50,307
Sale
Class A Common Stock 25,595 $11.41 $292,039
Option
Employee Stock Options (Right to Buy) 110,962 $11.65 $1,292,707
Option
Class A Common Stock 110,962 $11.65 $1,292,707
Sale
Class A Common Stock 110,962 $12.07 $1,339,311
Sale
Class A Common Stock 18,899 $10.41 $196,739
Sale
Class A Common Stock 26,446 $10.65 $281,650
Sale
Class A Common Stock 23,229 $11.35 $263,649
Sale
Class A Common Stock 19,959 $11.58 $231,125
Sale
Class A Common Stock 11,848 $11.5 $136,252
Sale
Class A Common Stock 2,587 $11.5 $29,751
Sale
Class A Common Stock 21,873 $11.5 $251,540
Sale
Class A Common Stock 16,486 $10.77 $177,554
Sale
Class A Common Stock 1,942 $10.77 $20,915
Sale
Class A Common Stock 10,026 $10.77 $107,980
Sale
Class A Common Stock 19,970 $10.77 $215,077
Sale
Class A Common Stock 46,327 $11.41 $528,591
Sale
Class A Common Stock 52,644 $11.58 $609,618
Sale
Class A Common Stock 1,716 $12.25 $21,021
Sale
Class A Common Stock 14,685 $9.11 $133,780
Sale
Class A Common Stock 14,685 $3.04 $44,598
Option
Employee Stock Option (Right to Buy) 99,988 N/A N/A
Option
Class A Common Stock 99,988 $9.89 $988,881
Sale
Class A Common Stock 1,697 $10.35 $17,564
Sale
Class A Common Stock 4,177 $11.63 $48,579
Option
Employee Stock Option (Right to Buy) 20,000 $10.02 $200,400
Option
Class A Common Stock 20,000 $10.02 $200,400
Sale
Class A Common Stock 20,000 $10.02 $200,400
Option
Employee Stock Option (Right to Buy) 220,000 $4.88 $1,073,600
Sale
Class A Common Stock 220,000 $9.24 $2,032,800
Option
Class A Common Stock 220,000 $4.88 $1,073,600
Sale
Class A Common Stock 4,055 $10.53 $42,699
Sale
Class A Common Stock 41 $14.32 $587
Sale
Class A Common Stock 4,800 $14.31 $68,688
Sale
Class B Common Stock 30,000 $5.48 $164,400
Option
Employee Stock Option(Right to Buy) 30,000 $5.48 $164,400
Option
Class B Common Stock 30,000 $5.48 $164,400
Sale
Class A Common Stock 3,343 $14.66 $49,008
Sale
Class B Common Stock 30,000 $5.48 $164,400
Option
Class B Common Stock 30,000 $5.48 $164,400
Option
Employee Stock Option (Right to Buy) 30,000 $5.48 $164,400
Sale
Class A Common Stock 1,520 $16.94 $25,749
Sale
Class A Common Stock 1,600 $8.5 $13,600
Option
Class B Common Stock 40,000 $5.48 $219,200
Option
Employee Stock Option (Right to Buy) 40,000 $5.48 $219,200
Sale
Class B Common Stock 40,000 $5.48 $219,200

Ironwood Pharmaceuticals key executives

Ironwood Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: